222 related articles for article (PubMed ID: 31299925)
1. Expression patterns of small numbers of transcripts from functionally-related pathways predict survival in multiple cancers.
Mandel J; Wang H; Normolle DP; Chen W; Yan Q; Lucas PC; Benos PV; Prochownik EV
BMC Cancer; 2019 Jul; 19(1):686. PubMed ID: 31299925
[TBL] [Abstract][Full Text] [Related]
2. Sequential analysis of transcript expression patterns improves survival prediction in multiple cancers.
Mandel J; Avula R; Prochownik EV
BMC Cancer; 2020 Apr; 20(1):297. PubMed ID: 32264880
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic implications of ribosomal protein transcript expression patterns in human cancers.
Dolezal JM; Dash AP; Prochownik EV
BMC Cancer; 2018 Mar; 18(1):275. PubMed ID: 29530001
[TBL] [Abstract][Full Text] [Related]
4. Sorting Five Human Tumor Types Reveals Specific Biomarkers and Background Classification Genes.
Roche KE; Weinstein M; Dunwoodie LJ; Poehlman WL; Feltus FA
Sci Rep; 2018 May; 8(1):8180. PubMed ID: 29802335
[TBL] [Abstract][Full Text] [Related]
5. The panoramic picture of pepsinogen gene family with pan-cancer.
Shen S; Li H; Liu J; Sun L; Yuan Y
Cancer Med; 2020 Dec; 9(23):9064-9080. PubMed ID: 33067881
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional profiles reveal histologic origin and prognosis across 33 The Cancer Genome Atlas tumor types.
Xiao H; Hu L; Tan Q; Jia J; Xie P; Li J; Wang M
Transl Cancer Res; 2023 Oct; 12(10):2764-2780. PubMed ID: 37969389
[TBL] [Abstract][Full Text] [Related]
7. TP53 mutations, expression and interaction networks in human cancers.
Wang X; Sun Q
Oncotarget; 2017 Jan; 8(1):624-643. PubMed ID: 27880943
[TBL] [Abstract][Full Text] [Related]
8. Analyzing the similarity of samples and genes by MG-PCC algorithm, t-SNE-SS and t-SNE-SG maps.
Jia X; Han Q; Lu Z
BMC Bioinformatics; 2018 Dec; 19(1):512. PubMed ID: 30558536
[TBL] [Abstract][Full Text] [Related]
9. Integration of transcriptomic data and metabolic networks in cancer samples reveals highly significant prognostic power.
Graudenzi A; Maspero D; Di Filippo M; Gnugnoli M; Isella C; Mauri G; Medico E; Antoniotti M; Damiani C
J Biomed Inform; 2018 Nov; 87():37-49. PubMed ID: 30244122
[TBL] [Abstract][Full Text] [Related]
10. Distinct signatures of codon and codon pair usage in 32 primary tumor types in the novel database CancerCoCoPUTs for cancer-specific codon usage.
Meyer D; Kames J; Bar H; Komar AA; Alexaki A; Ibla J; Hunt RC; Santana-Quintero LV; Golikov A; DiCuccio M; Kimchi-Sarfaty C
Genome Med; 2021 Jul; 13(1):122. PubMed ID: 34321100
[TBL] [Abstract][Full Text] [Related]
11. Quantification of intrinsic subtype ambiguity in Luminal A breast cancer and its relationship to clinical outcomes.
Kumar N; Zhao D; Bhaumik D; Sethi A; Gann PH
BMC Cancer; 2019 Mar; 19(1):215. PubMed ID: 30849944
[TBL] [Abstract][Full Text] [Related]
12. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors.
Glinsky GV
Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790
[TBL] [Abstract][Full Text] [Related]
13. A high-risk luminal A dominant breast cancer subtype with increased mobility.
Guo L; Chen G; Zhang W; Zhou L; Xiao T; Di X; Wang Y; Feng L; Zhang K
Breast Cancer Res Treat; 2019 Jun; 175(2):459-472. PubMed ID: 30778902
[TBL] [Abstract][Full Text] [Related]
14. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
15. Evaluation on the diagnostic and prognostic values of long non-coding RNA BLACAT1 in common types of human cancer.
Chen X; Dai M; Zhu H; Li J; Huang Z; Liu X; Huang Y; Chen J; Dai S
Mol Cancer; 2017 Oct; 16(1):160. PubMed ID: 29037201
[TBL] [Abstract][Full Text] [Related]
16. Impact of Tumor Purity on Immune Gene Expression and Clustering Analyses across Multiple Cancer Types.
Rhee JK; Jung YC; Kim KR; Yoo J; Kim J; Lee YJ; Ko YH; Lee HH; Cho BC; Kim TM
Cancer Immunol Res; 2018 Jan; 6(1):87-97. PubMed ID: 29141981
[TBL] [Abstract][Full Text] [Related]
17. Data-driven identification of prognostic tumor subpopulations using spatially mapped t-SNE of mass spectrometry imaging data.
Abdelmoula WM; Balluff B; Englert S; Dijkstra J; Reinders MJ; Walch A; McDonnell LA; Lelieveldt BP
Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12244-12249. PubMed ID: 27791011
[TBL] [Abstract][Full Text] [Related]
18. Assessing the clinical utility of genomic expression data across human cancers.
Xu X; Huang L; Chan CH; Yu T; Miao R; Liu C
Oncotarget; 2016 Jul; 7(29):45926-45936. PubMed ID: 27322207
[TBL] [Abstract][Full Text] [Related]
19. Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data.
Hao Y; Li D; Xu Y; Ouyang J; Wang Y; Zhang Y; Li B; Xie L; Qin G
BMC Bioinformatics; 2019 May; 20(Suppl 7):195. PubMed ID: 31074374
[TBL] [Abstract][Full Text] [Related]
20. A robust panel based on tumour microenvironment genes for prognostic prediction and tailoring therapies in stage I-III colon cancer.
Zhou R; Zeng D; Zhang J; Sun H; Wu J; Li N; Liang L; Shi M; Bin J; Liao Y; Huang N; Liao W
EBioMedicine; 2019 Apr; 42():420-430. PubMed ID: 30917936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
